Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Assurant raises 2025 outlook to low double-digit EPS growth amid new partnerships and strong housing... (SeekingAlpha) +++ ASSURANT Aktie +4,81%

CENCORA Aktie

 >CENCORA Aktienkurs 
314.55 EUR    +4.8%    (Tradegate)
Ask: 308.05 EUR / 100 Stück
Bid: 306.2 EUR / 100 Stück
Tagesumsatz: 18 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
CENCORA Aktie über LYNX handeln
>CENCORA Performance
1 Woche: +4,2%
1 Monat: +15,6%
3 Monate: +18,8%
6 Monate: +16,4%
1 Jahr: +41,3%
laufendes Jahr: +38,9%
>CENCORA Aktie
Name:  CENCORA DL-,01
Land:  USA
Sektor:  Handel
ISIN/ Wkn:  US03073E1055 / 766149
Symbol/ Ticker:  ABG (Frankfurt) / COR (NYSE)
Kürzel:  FRA:ABG, ETR:ABG, ABG:GR, NYSE:COR
Index:  S&P500
Webseite:  https://www.cencora.com/
Profil:  Cencora Inc., formerly known as AmerisourceBergen ..
>Volltext..
Marktkapitalisierung:  57525.22 Mio. EUR
Unternehmenswert:  62796.64 Mio. EUR
Umsatz:  275581.68 Mio. EUR
EBITDA:  3952.27 Mio. EUR
Nettogewinn:  1651.17 Mio. EUR
Gewinn je Aktie:  8.52 EUR
Schulden:  7171.63 Mio. EUR
Liquide Mittel:  1980.2 Mio. EUR
Operativer Cashflow:  1516.12 Mio. EUR
Bargeldquote:  0.04
Umsatzwachstum:  1.44%
Gewinnwachstum:  -7.07%
Dividende je Aktie:  0.7 EUR
Dividendenrendite:  0.65%
Dividendenschätzung:  0.65%
Div. Historie:  08.09.25 - 0.18017998€
09.06.25 - 0.18017998€
>weitere anzeigen...
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 1.665.700 USD.
Suchwörter:  CENCORA, AMERISOURCEBERGEN
Letzte Datenerhebung:  05.11.25
>CENCORA Kennzahlen
Aktien/ Unternehmen:
Aktien: 193.88 Mio. St.
Frei handelbar: 95.81%
Rückkaufquote: 1.38%
Mitarbeiter: 46000
Umsatz/Mitarb.: 5.56 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 2.61%
Bewertung:
KGV: 35.44
KGV lG: 21.53
KUV: 0.21
KBV: 33.73
PEG-Ratio: 6.22
EV/EBITDA: 15.89
Rentabilität:
Bruttomarge: 3.06%
Gewinnmarge: 0.6%
Operative Marge: 1.09%
Managementeffizenz:
Gesamtkaprendite: 2.7%
Eigenkaprendite: 130.6%
>CENCORA Peer Group

Es sind 176 Aktien bekannt.
 
05.11.25 - 16:49
Cencora (COR) Q4 2025 Earnings Call Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 16:45
Cencora (COR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
 
Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
05.11.25 - 15:39
Cencora raises dividend by 9.1% to $0.60 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 15:15
Cencora (COR) Q4 Earnings and Revenues Surpass Estimates (Zacks)
 
Cencora (COR) delivered earnings and revenue surprises of +1.32% and +0.69%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
05.11.25 - 15:12
Cencora eying $1B investment to boost U.S. supply chain (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 15:01
Cencora Posts Loss In Q4; Raises Long-term Guidance (AFX)
 
WASHINGTON (dpa-AFX) - Cencora, Inc. (COR) reported a fourth quarter net loss attributable to company of $339.7 million compared to profit of $3.4 million, last year. Loss per share was $1.75, com......
05.11.25 - 14:12
Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 13:06
Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain (WSJ EN)
 
The company will open two new distribution centers and expand a third as demand surges for GLP-1s and other refrigerated medications....
05.11.25 - 12:36
Cencora Non-GAAP EPS of $3.84 beats by $0.05, revenue of $83.7B beats by $310M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 12:33
Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results (Business Wire)
 
Revenue of $83.7 Billion for the Fourth Quarter, a 5.9 Percent Year-Over-Year Increase Fourth Quarter GAAP Diluted EPS of $(1.75) and Adjusted Diluted EPS of $3.84 Revenue of $321.3 Billion for Fiscal Year 2025, a 9.3 Percent Year-Over-Year Increase Fiscal Year 2025 GAAP Diluted EPS of $7.96 and Adjusted Diluted EPS of $16.00 Company increases its quarterly dividend by 9 percent Company raises its long-term guidance expectations CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2025 fourth quarter ended September 30, 2025, revenue increased 5.9 percent to $83.7 billion. Revenue increased 9.3 percent to $321.3 billion for fiscal year 2025. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $(1.75) for the September quarter of fiscal 2025, compared to $0.02 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described below, increased 15.0 percent to $3.84 i...
31.10.25 - 16:45
Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3 (Zacks)
 
Humana, Cencora and Globus Medical are poised to outshine in the September quarter, driven by strong demand, innovation and volume growth....
29.10.25 - 16:30
Cencora (COR) Earnings Expected to Grow: Should You Buy? (Zacks)
 
Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
22.10.25 - 15:18
What to Expect From Cencora′s Q4 2025 Earnings Report (Barchart)
 
Cencora is scheduled to release its fourth-quarter results next month, with analysts projecting double-digit earnings growth....
22.10.25 - 02:01
Insiderhandel: President & CEO verkauft Aktien von Cencora im Wert von 1665700 USD (Insiderkauf)
 
Mauch, Robert P. - Vorstand - Tag der Transaktion: 2025-10-20...
21.10.25 - 19:45
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
 
Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....
17.10.25 - 21:36
Moody′s stuft Cencora auf Baa1 hoch (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
13.10.25 - 17:30
Here′s Why Cencora (COR) is a Strong Growth Stock (Zacks)
 
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....
06.10.25 - 22:33
Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release (Business Wire)
 
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2025 on Wednesday, November 5, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on November 5, 2025. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President & Chief Financial Officer The live call will be webcast via the Company's website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call. To access the call via telephone from within the United States and Canada, dial +1 (833) 470-1428. From outside the United States and Canada, dial +1 (646) 844-6383. The access code for the call will be 837725. Replays of the call will be made available via telephone and webcast. A replay of the we...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!